 | • レポートコード：GIR-105X19751 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、滅菌医薬品有効成分のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。滅菌医薬品有効成分の種類別市場規模（水性、非水性液体、乾燥粉末、その他）、用途別市場規模（CNS、心臓血管、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・滅菌医薬品有効成分の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aurobindo Pharma、Teva Pharmaceutical Industries、Corden Pharma、Dalton Pharma Services、Pfizer、Sun Pharmaceutical Industries、Lonza Group、Albany Molecular Research、Sanofi、Dr. Reddy’s Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：水性、非水性液体、乾燥粉末、その他 ・用途別分析2016年-2026年：CNS、心臓血管、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍、その他 ・滅菌医薬品有効成分の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・滅菌医薬品有効成分のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・滅菌医薬品有効成分のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・滅菌医薬品有効成分の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・滅菌医薬品有効成分の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Sterile Active Pharmaceutical Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Sterile Active Pharmaceutical Ingredients size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Sterile Active Pharmaceutical Ingredients market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Sterile Active Pharmaceutical Ingredients market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Aqueous
Non-aqueous Liquid
Dry Powder
Others
Market segment by Application can be divided into
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
The key market players for global Sterile Active Pharmaceutical Ingredients market are listed below:
Aurobindo Pharma
Teva Pharmaceutical Industries
Corden Pharma
Dalton Pharma Services
Pfizer
Sun Pharmaceutical Industries
Lonza Group
Albany Molecular Research
Sanofi
Dr. Reddy’s Laboratories
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Sterile Active Pharmaceutical Ingredients Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sterile Active Pharmaceutical Ingredients Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Aqueous
1.2.3 Non-aqueous Liquid
1.2.4 Dry Powder
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sterile Active Pharmaceutical Ingredients Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Global Sterile Active Pharmaceutical Ingredients Market Size & Forecast
1.4.1 Global Sterile Active Pharmaceutical Ingredients Sales in Value (2016-2026))
1.4.2 Global Sterile Active Pharmaceutical Ingredients Sales in Volume (2016-2026)
1.4.3 Global Sterile Active Pharmaceutical Ingredients Price by Type (2016-2026) & (US$/Ton)
1.5 Global Sterile Active Pharmaceutical Ingredients Production Capacity Analysis
1.5.1 Global Sterile Active Pharmaceutical Ingredients Total Production Capacity (2016-2026)
1.5.2 Global Sterile Active Pharmaceutical Ingredients Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sterile Active Pharmaceutical Ingredients Market Drivers
1.6.2 Sterile Active Pharmaceutical Ingredients Market Restraints
1.6.3 Sterile Active Pharmaceutical Ingredients Trends Analysis
2 Manufacturers Profiles
2.1 Aurobindo Pharma
2.1.1 Aurobindo Pharma Details
2.1.2 Aurobindo Pharma Major Business
2.1.3 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Product and Services
2.1.4 Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Teva Pharmaceutical Industries
2.2.1 Teva Pharmaceutical Industries Details
2.2.2 Teva Pharmaceutical Industries Major Business
2.2.3 Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product and Services
2.2.4 Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Corden Pharma
2.3.1 Corden Pharma Details
2.3.2 Corden Pharma Major Business
2.3.3 Corden Pharma Sterile Active Pharmaceutical Ingredients Product and Services
2.3.4 Corden Pharma Sterile Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Dalton Pharma Services
2.4.1 Dalton Pharma Services Details
2.4.2 Dalton Pharma Services Major Business
2.4.3 Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Product and Services
2.4.4 Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Sterile Active Pharmaceutical Ingredients Product and Services
2.5.4 Pfizer Sterile Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sun Pharmaceutical Industries
2.6.1 Sun Pharmaceutical Industries Details
2.6.2 Sun Pharmaceutical Industries Major Business
2.6.3 Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product and Services
2.6.4 Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Lonza Group
2.7.1 Lonza Group Details
2.7.2 Lonza Group Major Business
2.7.3 Lonza Group Sterile Active Pharmaceutical Ingredients Product and Services
2.7.4 Lonza Group Sterile Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Albany Molecular Research
2.8.1 Albany Molecular Research Details
2.8.2 Albany Molecular Research Major Business
2.8.3 Albany Molecular Research Sterile Active Pharmaceutical Ingredients Product and Services
2.8.4 Albany Molecular Research Sterile Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Sterile Active Pharmaceutical Ingredients Product and Services
2.9.4 Sanofi Sterile Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Dr. Reddy’s Laboratories
2.10.1 Dr. Reddy’s Laboratories Details
2.10.2 Dr. Reddy’s Laboratories Major Business
2.10.3 Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Product and Services
2.10.4 Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Sterile Active Pharmaceutical Ingredients Sales by Manufacturer
3.1 Global Sterile Active Pharmaceutical Ingredients Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Sterile Active Pharmaceutical Ingredients Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Sterile Active Pharmaceutical Ingredients
3.4 Market Concentration Rate
3.4.1 Top 3 Sterile Active Pharmaceutical Ingredients Manufacturer Market Share
3.4.2 Top 6 Sterile Active Pharmaceutical Ingredients Manufacturer Market Share
3.5 Global Sterile Active Pharmaceutical Ingredients Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Sterile Active Pharmaceutical Ingredients Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sterile Active Pharmaceutical Ingredients Market Size by Region
4.1.1 Global Sterile Active Pharmaceutical Ingredients Sales in Volume by Region (2016-2026)
4.1.2 Global Sterile Active Pharmaceutical Ingredients Revenue by Region (2016-2026)
4.2 North America Sterile Active Pharmaceutical Ingredients Revenue (2016-2026)
4.3 Europe Sterile Active Pharmaceutical Ingredients Revenue (2016-2026)
4.4 Asia-Pacific Sterile Active Pharmaceutical Ingredients Revenue (2016-2026)
4.5 South America Sterile Active Pharmaceutical Ingredients Revenue (2016-2026)
4.6 Middle East and Africa Sterile Active Pharmaceutical Ingredients Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Sterile Active Pharmaceutical Ingredients Sales in Volume by Type (2016-2026)
5.2 Global Sterile Active Pharmaceutical Ingredients Revenue by Type (2016-2026)
5.3 Global Sterile Active Pharmaceutical Ingredients Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Sterile Active Pharmaceutical Ingredients Sales in Volume by Application (2016-2026)
6.2 Global Sterile Active Pharmaceutical Ingredients Revenue by Application (2016-2026)
6.3 Global Sterile Active Pharmaceutical Ingredients Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2026)
7.2 North America Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2026)
7.3 North America Sterile Active Pharmaceutical Ingredients Market Size by Country
7.3.1 North America Sterile Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
7.3.2 North America Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2026)
8.2 Europe Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2026)
8.3 Europe Sterile Active Pharmaceutical Ingredients Market Size by Country
8.3.1 Europe Sterile Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
8.3.2 Europe Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2026)
9.2 Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2026)
9.3 Asia-Pacific Sterile Active Pharmaceutical Ingredients Market Size by Region
9.3.1 Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Sterile Active Pharmaceutical Ingredients Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2026)
10.2 South America Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2026)
10.3 South America Sterile Active Pharmaceutical Ingredients Market Size by Country
10.3.1 South America Sterile Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
10.3.2 South America Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2026)
11.2 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2026)
11.3 Middle East & Africa Sterile Active Pharmaceutical Ingredients Market Size by Country
11.3.1 Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Sterile Active Pharmaceutical Ingredients Typical Distributors
12.3 Sterile Active Pharmaceutical Ingredients Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Sterile Active Pharmaceutical Ingredients Revenue by Type, (USD Million), 2021-2026
Table 2. Global Sterile Active Pharmaceutical Ingredients Revenue by Application, (USD Million), 2021-2026
Table 3. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Aurobindo Pharma Major Business
Table 5. Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Product and Services
Table 6. Aurobindo Pharma Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 8. Teva Pharmaceutical Industries Major Business
Table 9. Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product and Services
Table 10. Teva Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Corden Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Corden Pharma Major Business
Table 13. Corden Pharma Sterile Active Pharmaceutical Ingredients Product and Services
Table 14. Corden Pharma Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Dalton Pharma Services Basic Information, Manufacturing Base and Competitors
Table 16. Dalton Pharma Services Major Business
Table 17. Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Product and Services
Table 18. Dalton Pharma Services Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Sterile Active Pharmaceutical Ingredients Product and Services
Table 22. Pfizer Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 24. Sun Pharmaceutical Industries Major Business
Table 25. Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Product and Services
Table 26. Sun Pharmaceutical Industries Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 28. Lonza Group Major Business
Table 29. Lonza Group Sterile Active Pharmaceutical Ingredients Product and Services
Table 30. Lonza Group Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Albany Molecular Research Basic Information, Manufacturing Base and Competitors
Table 32. Albany Molecular Research Major Business
Table 33. Albany Molecular Research Sterile Active Pharmaceutical Ingredients Product and Services
Table 34. Albany Molecular Research Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Sterile Active Pharmaceutical Ingredients Product and Services
Table 38. Sanofi Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 40. Dr. Reddy’s Laboratories Major Business
Table 41. Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Product and Services
Table 42. Dr. Reddy’s Laboratories Sterile Active Pharmaceutical Ingredients Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Sterile Active Pharmaceutical Ingredients Sales by Manufacturer (2019-2021e) & (Kiloton)
Table 44. Global Sterile Active Pharmaceutical Ingredients Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Sterile Active Pharmaceutical Ingredients, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Sterile Active Pharmaceutical Ingredients Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 47. Head Office and Sterile Active Pharmaceutical Ingredients Production Site of Key Manufacturer
Table 48. Global Sterile Active Pharmaceutical Ingredients Sales by Region (2016-2021e) & (Kiloton)
Table 49. Global Sterile Active Pharmaceutical Ingredients Sales by Region (2021-2026) & (Kiloton)
Table 50. Global Sterile Active Pharmaceutical Ingredients Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Sterile Active Pharmaceutical Ingredients Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (Kiloton)
Table 53. Global Sterile Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (Kiloton)
Table 54. Global Sterile Active Pharmaceutical Ingredients Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Sterile Active Pharmaceutical Ingredients Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Sterile Active Pharmaceutical Ingredients Price by Type (2016-2021e) & (US$/Ton)
Table 57. Global Sterile Active Pharmaceutical Ingredients Price by Type (2021-2026) & (US$/Ton)
Table 58. Global Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (Kiloton)
Table 59. Global Sterile Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (Kiloton)
Table 60. Global Sterile Active Pharmaceutical Ingredients Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Sterile Active Pharmaceutical Ingredients Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Sterile Active Pharmaceutical Ingredients Price by Application (2016-2021e) & (US$/Ton)
Table 63. Global Sterile Active Pharmaceutical Ingredients Price by Application (2021-2026) & (US$/Ton)
Table 64. North America Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (Kiloton)
Table 65. North America Sterile Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (Kiloton)
Table 66. North America Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Sterile Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (Kiloton)
Table 69. North America Sterile Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (Kiloton)
Table 70. North America Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (Kiloton)
Table 71. North America Sterile Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (Kiloton)
Table 72. Europe Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (Kiloton)
Table 73. Europe Sterile Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (Kiloton)
Table 74. Europe Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Sterile Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (Kiloton)
Table 77. Europe Sterile Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (Kiloton)
Table 78. Europe Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (Kiloton)
Table 79. Europe Sterile Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (Kiloton)
Table 80. Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales by Region (2016-2021e) & (Kiloton)
Table 81. Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales by Region (2021-2026) & (Kiloton)
Table 82. Asia-Pacific Sterile Active Pharmaceutical Ingredients Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Sterile Active Pharmaceutical Ingredients Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (Kiloton)
Table 85. Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (Kiloton)
Table 86. Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (Kiloton)
Table 87. Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (Kiloton)
Table 88. South America Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (Kiloton)
Table 89. South America Sterile Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (Kiloton)
Table 90. South America Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Sterile Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (Kiloton)
Table 93. South America Sterile Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (Kiloton)
Table 94. South America Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (Kiloton)
Table 95. South America Sterile Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (Kiloton)
Table 96. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Country (2016-2021e) & (Kiloton)
Table 97. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Country (2021-2026) & (Kiloton)
Table 98. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Type (2016-2021e) & (Kiloton)
Table 101. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Type (2021-2026) & (Kiloton)
Table 102. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Application (2016-2021e) & (Kiloton)
Table 103. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales by Application (2021-2026) & (Kiloton)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Sterile Active Pharmaceutical Ingredients Typical Distributors
Table 107. Sterile Active Pharmaceutical Ingredients Typical Customers
List of Figures
Figure 1. Sterile Active Pharmaceutical Ingredients Picture
Figure 2. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type in 2020
Figure 3. Aqueous
Figure 4. Non-aqueous Liquid
Figure 5. Dry Powder
Figure 6. Others
Figure 7. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Application in 2020
Figure 8. CNS
Figure 9. Cardiovascular
Figure 10. Genitourinary/Hormonal Drugs
Figure 11. Respiratory
Figure 12. Rheumatology
Figure 13. Diabetes
Figure 14. Oncology
Figure 15. Others
Figure 16. Global Sterile Active Pharmaceutical Ingredients Market Size, (USD Million) & (Kiloton): 2020 VS 2021 VS 2026
Figure 17. Global Sterile Active Pharmaceutical Ingredients Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. United States Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Canada Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Mexico Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Germany Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. France Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. United Kingdom Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Russia Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Italy Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. China Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Japan Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Korea Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. India Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Southeast Asia Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Australia Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Brazil Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Egypt Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Saudi Arabia Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. South Africa Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Turkey Sterile Active Pharmaceutical Ingredients Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Global Sterile Active Pharmaceutical Ingredients Sales (2016-2026) & (Kiloton)
Figure 38. Global Sterile Active Pharmaceutical Ingredients Production Capacity (2016-2026) & (Kiloton)
Figure 39. Global Sterile Active Pharmaceutical Ingredients Production Capacity by Geographic Region: 2020 VS 2021
Figure 40. Sterile Active Pharmaceutical Ingredients Market Drivers
Figure 41. Sterile Active Pharmaceutical Ingredients Market Restraints
Figure 42. Sterile Active Pharmaceutical Ingredients Market Trends
Figure 43. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Manufacturer in 2020
Figure 44. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Manufacturer in 2020
Figure 45. Sterile Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 46. Top 3 Sterile Active Pharmaceutical Ingredients Manufacturer (Revenue) Market Share in 2020
Figure 47. Top 6 Sterile Active Pharmaceutical Ingredients Manufacturer (Revenue) Market Share in 2020
Figure 48. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2026)
Figure 49. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2026)
Figure 50. North America Sterile Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 51. Europe Sterile Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Sterile Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 53. South America Sterile Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 54. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue (2016-2026) & (USD Million)
Figure 55. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 56. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2026)
Figure 57. Global Sterile Active Pharmaceutical Ingredients Price by Type (2016-2026) & (US$/Ton)
Figure 58. Global Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 59. Global Sterile Active Pharmaceutical Ingredients Revenue Market Share by Application (2016-2026)
Figure 60. Global Sterile Active Pharmaceutical Ingredients Price by Application (2016-2026) & (US$/Ton)
Figure 61. North America Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 62. North America Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 63. North America Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 64. North America Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 65. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 66. Europe Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 67. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 68. Europe Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Sterile Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2026)
Figure 72. Asia-Pacific Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 73. South America Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 74. South America Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 75. South America Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 76. South America Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Sterile Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2026)
Figure 80. Middle East & Africa Sterile Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2026)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界の特殊有効成分市場 2021：企業別、地域別、種類・用途別 The Specialty Active Pharmaceutical Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…- 高力活性医薬成分（API）の世界市場予測 2023年：メーカー別、地域別、種類・用途別 High Potency Active Pharmaceutical Ingredients (APIs) have higher active level targeting sever diseases such as tumour cells, infected cells, damaged organs than regular medicine elements. Scope of the Report: This report focuses on the High Potency Active Pharmaceutical Ingredients (APIs) in global…
- パーソナルケア用活性成分の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Active ingredients provide several benefits for various personal care products. Scope of the Report: This report focuses on the Personal Care Active Ingredients in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the …
- 世界の滅菌ゴム栓市場 2021：企業別、地域別、種類・用途別 The Sterile Rubber Stopper market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の注射用滅菌溶液市場 2021：企業別、地域別、種類・用途別 The Sterile Solution for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …